Protocol No
GI-MERCK-MK7240-001
Staff Member
Poonam Beniwal-Patel
Phase
III
Summary
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active ulcerative colitis.
Objective
Efficacy and Safety of MK-7240 in Participants With Moderately to Severely Active Ulcerative Colitis
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov